Belantamab mafodotin
Belantamab mafodotin (GSK2857916) is composed of humanized and focused monoclonal antibody against B cell maturation antigen (BCMA) and McMMAF. The antibody portion is Belantamab , and the drug-linker conjugate for ADC is McMMAF (HY-15578). Belantamab mafodotin has anti-myeloma activity[1][2].
Product Specifications
CAS Number
2050232-20-5
Product Name Alternative
GSK2857916; Belantamab mafodotin-blm
UNSPSC
12352203
Target
Antibody-Drug Conjugates (ADCs)
Type
ADC Related
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/belantamab-mafodotin.html
Purity
99.78
Solubility
10 mM in DMSO
Smiles
[Belantamabmafodotin]
Molecular Weight
149000 (average)
References & Citations
[1]Hulin C, et al. Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2) : a two-arm, randomised, open-label, phase 2 study. Lancet Oncol. 2020 Feb;21 (2) :207-221.|[2]Markham A. Belantamab Mafodotin: First Approval. Drugs. 2020 Oct;80 (15) :1607-1613.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C, protect from light
Scientific Category
ADC Related
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PB9675-APC 100 µg/Vial
Anti-SHP2/PTPN11 Antibody Picoband® (APC Conjugate)
Sign In for Pricing
View Details 
BNC473812-100 1x 100 µL
Thymidylate Synthase (5-FU Resistance Marker) (rTYMS/1884), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details ![Ethyl 2-[ (ethoxymethanethioyl) sulfanyl]-2-fluoroacetate](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
IKB85757-01 50 mg
Ethyl 2-[ (ethoxymethanethioyl) sulfanyl]-2-fluoroacetate
Sign In for Pricing
View Details